Fe3 Medical develops a drug delivery technology for non-toxic iron transportation across the skin for patients with iron-deficiency anemia.
Fe3 Medical Inc. engages in commercialization of a drug delivery technology that enables the safe, non-toxic transport of approximately 10 milligrams of iron across the skin for those who suffer with iron-deficiency anemia.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 8, 2016 | Series B | $3.50M | 1 | — | — | Detail |
Mar 2, 2016 | Series B | $11M | 1 | Jianmin Pharmaceuticals | — | Detail |
Sep 28, 2010 | Series Unknown | $2.80M | 1 | Texas Wide Open for Business | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Texas Wide Open for Business | Yes | Series Unknown |
Jianmin Pharmaceuticals | — | Series B |